This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,350 Years Active: 2001
Title: Daniel Tusé: Innovator in Anti-Cancer Research
Introduction
Daniel Tusé is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of anti-cancer research through his innovative work. His research focuses on developing compounds that can effectively inhibit tumor cell growth.
Latest Patents
Daniel Tusé holds a patent for "Di-aryl ethers and their derivatives as anti-cancer agents." This invention relates to compounds that bind tubulin and exhibit anti-mitotic properties. The methods outlined in his patent aim to inhibit abnormal cell mitosis, particularly targeting tumor cell growth. Additionally, the patent presents methods for treating mammalian diseases associated with undesired and uncontrolled angiogenesis.
Career Highlights
Throughout his career, Daniel Tusé has demonstrated a commitment to advancing cancer treatment methodologies. His innovative approach has led to the development of valuable compounds that hold promise in the fight against cancer. His work is characterized by a strong focus on practical applications that can benefit patients.
Collaborations
Daniel has collaborated with notable colleagues, including Xiaoying Chen and Keith R. Laderoute. These partnerships have enhanced the scope and impact of his research, contributing to the advancement of anti-cancer therapies.
Conclusion
In summary, Daniel Tusé is a dedicated inventor whose work in anti-cancer research has the potential to make a significant impact on treatment options. His innovative compounds and methods represent a step forward in the fight against cancer.